Genetic ‘Immune Landscape’ Determines Progression of Prostate Cancer, Mice Study Suggests

Genetic ‘Immune Landscape’ Determines Progression of Prostate Cancer, Mice Study Suggests
Genetic variations that drive prostate cancer dictate the composition of immune cells within tumors and response to treatment, a new study shows. Researchers at the Beth Israel Deaconess Medical Center (BIDMC) suggest that profiling a patient’s tumor could help tailoring immunotherapies and identify patients who are most responsive to certain treatments. The research, “Diverse genetic-driven immune

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. As my father was diagnosed with PC (75 yo, gleason 8, psa 11, stage T2b)I wanted to help him as he doesn’t have any access to the Internet. After 2 months of searching I can now say that I’m quite good informed about the disease, the treatments etc. But I still have some critical questions: what is the turning point, after which this “mild” form of cancer turns into an agressive one and kills the patient?

Leave a Comment

Your email address will not be published. Required fields are marked *